https://www.selleckchem.com/products/cia1.html Given the poor prognosis of MYC-overexpressing diffuse large B cell lymphoma (DLBCL) and B cell lymphoma unclassifiable with features intermediate between DLBCL and Burkitt lymphoma/high grade B cell lymphoma (BCLU/HGBL), and preclinical data suggesting that MYC may regulate the antitumor immune response, we sought to characterize expression of immune checkpoint proteins on tumor tissue from patients diagnosed with these lymphomas. Immunohistochemical staining for immune checkpoint protein expression was applied to 56 cases of MYC-overexpressing DLBCL and BCLU/HGBL, 35 of which also harbored MYC rearrangement (MYC-R). Analysis revealed both frequent overexpression of immune checkpoint proteins as well as differences in overexpression patterns based upon MYC-R status, with MYC-R cases more likely to overexpress PD-L1 and PD-1 in the tumor microenvironment (50 vs. 15%, p = 0.02 and 32 vs. 5%, p = 0.02, respectively) but less likely to overexpress CTLA-4 and CD80 on tumor cells (34 vs. 71%, p = 0.01 and 34 vs. 81%, p = 0.001, respectively), as compared to cases without MYC-R. These data may suggest a biologic rationale for investigation of the effect of checkpoint inhibitor therapies in these subgroups of MYC-overexpressing DLBCL and BCLU/HGBL. Study aimed to assess short- and long-term impact of unilateral cochlear implantation in children on the angular vestibulo-ocular reflex using rotatory chair test. Two groups; A (early postoperative evaluation) and B (later on evaluation) were included, each consisted of 23 cochlear implant candidates' children with unilateral implant surgeries were performed in El-Galaa Hospital, Cairo, Egypt. They were assessed by rotatory chair test; sinusoidal harmonic acceleration paradigm. Three parameters average gain, asymmetry, and phase results of each group were compared with the manufacturer's norms and with each other. Further analysis by comparing each group implanted side specific gai